TIG Advisors LLC’s Day One Biopharmaceuticals DAWN Stock Holding History

TIG Advisors LLC’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-613,918	Closed	-$13.2M	–	121
2026 Q1	$13.2M	Buy	+613,918	New	+$8.65M	0.61%	35

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TIG Advisors LLC's DAWN Position: Q2 2026 in Review

TIG Advisors LLC sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 613,918 shares — an estimated $13.2M sold.

TIG Advisors LLC first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $13.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

TIG Advisors LLC reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
TIG Advisors LLC sold 613,918 Day One Biopharmaceuticals shares in Q2 2026, an estimated $13.2M.
TIG Advisors LLC first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
TIG Advisors LLC's Day One Biopharmaceuticals position peaked at $13.2M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on TIG Advisors LLC's 13F filing for Q2 2026, filed 14 Aug 2026.